CLV is experiencing cyclically low demand for its products caused by a backlog of infant formula in China from a change in infant formula standards and lower birth numbers in many developed nations.
What is covered in the Full Insight:
Introduction
FY24 Results Overview
Market Opportunities and Threats
Financial Forecasts
Conclusion and Recommendations
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.